Pfizer will sell nearly 500 vaccines and drugs at cost price to the poorest countries

U.S. pharmaceutical giant Pfizer said on Tuesday it would sell nearly 500 of its vaccines and drugs at cost to poorer countries, expanding on a previous commitment to reduce global health inequalities.

In May 2022, the group had indicated, as part of an initiative announced at the Davos Economic Forum, that it would supply 23 of its vaccines and patented medicines available in the United States and the European Union to 45 poor countries. – the equivalent of 1.2 billion people.

“Pfizer will now expand its offering under the agreement to include off-patent products, bringing the total of products offered from 23 to approximately 500.“, the company said in a statement.

These are all products for which Pfizer has worldwide rights, she said.